切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - F1 Fo-ATPase - Protease-Activated Receptors - Voltage-gated Sodium (NaV) Channels

13件产品中的 1-10

页面
每页
清除全部
  1. ProTx II
    B5515 ProTx II
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: NaV1.7通道阻断剂
      Soluble to 1 mg/mL
  2. Quinidine
    B7590 Quinidine
    中文名: 奎尼丁
    Target: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)
    Summary: 降低Na+和K+通道电流
      ≥11.95 mg/mL
      insoluble in H2O
  3. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  4. Bupivacaine HCl
    B1420 Bupivacaine HCl
    中文名: 盐酸布比卡因
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 麻醉药
      ≥10.25 mg/mL
      ≥16.23 mg/mL
  5. Phenytoin sodium
    B2272 Phenytoin sodium
    中文名: 苯妥英钠
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 钠通道稳定剂
      ≥11.55 mg/mL
      insoluble in H2O
  6. Proparacaine HCl
    B2274 Proparacaine HCl
    中文名: 盐酸丙美卡因
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 电压门控钠通道拮抗剂
      ≥14.9 mg/mL
      ≥17.73 mg/mL
  7. A-803467
    B2277 A-803467
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: NaV1.8通道阻断剂
      ≥13.95 mg/mL
      insoluble in H2O
  8. BTB06584
    B3041 BTB06584
    Target: F1 Fo-ATPase
    Summary: F1F0 ATP合酶抑制剂
      ≥17.05 mg/mL
      insoluble in H2O
  9. Vorapaxar
    A8809 Vorapaxar
    中文名: 沃拉帕沙
    Target: Protease-Activated Receptors
    Summary: PAR-1拮抗剂
      ≥24.65 mg/mL
      insoluble in H2O
  10. Riluzole
    A8513 Riluzole
    中文名: 力鲁唑
    Target: Voltage-gated Sodium (NaV) Channels|glutamate release
    Summary: 钠通道抑制剂
      ≥23.4 mg/mL
      insoluble in H2O

13件产品中的 1-10

页面
每页